Pharmaceuticals, Biotechnology and Life Sciences
NEW YORK, Jan. 14, 2026 (GLOBE NEWSWIRE) — Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence BioMed” or the “Company”), today announced…
Operating Expenses Decline 4% Year-to-DateBalance Sheet Strengthens and Working Capital Improves by 14.7% IRVINE, Calif., Jan. 14, 2026 (GLOBE NEWSWIRE)…
AJOVY demonstrated efficacy and a consistent safety profile in the SPACE trial, making it the first and only calcitonin gene-related…
Antidepressive effects and enhanced wakefulness were observed with OX2R activation in established animal model of major depressive disorderBOSTON and LONDON,…
Results demonstrate a significant survival benefit in the cTMB-H / HRP subset: median OS of almost 6 years (68 months)…
— The transaction is intended to strengthen the balance sheet, lower interest expense, reduce dilution, and significantly extend debt maturity…
Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code…
Partnership brings the proprietary technology behind Click’s FDA-authorized digital migraine intervention to the Ultrahuman platform Migraine PowerPlug Ultrahuman and Click…
CHICAGO, Jan. 14, 2026 (GLOBE NEWSWIRE) — Cosmos Health Inc. (“Cosmos Health” or the “Company”) (NASDAQ:COSM), a diversified, vertically integrated…
BERWYN, Pa., Jan. 14, 2026 (GLOBE NEWSWIRE) — AscellaHealth, a global partner delivering customizable solutions for the specialty pharmaceutical industry,…